Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...
TWO high-flying TAC chiefs spent $46,000 on a 12-day European “study tour”, travelling first-class, staying in five-star hotels and billing the taxpayer for tips, coffee, and stationery. The Transport ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback